Mon Sep 23 14:34:37 UTC 2024: ## Bausch + Lomb Stock Sees Increased Activity After Stifel Nicolaus Price Target Hike
**New York, NY –** Shares of Bausch + Lomb Co. (NYSE: BLCO) experienced a surge in trading volume on Monday, September 23rd, following an upward revision of the price target by Stifel Nicolaus. The firm increased its target from $16.00 to $19.00, while maintaining a “hold” rating on the stock.
The increased optimism from Stifel Nicolaus contributed to a 23% decline in trading volume compared to the previous session, with approximately 429,130 shares changing hands. The stock closed at $19.71, slightly down from its previous close of $19.96.
This recent activity comes amidst a mixed sentiment from other research firms regarding Bausch + Lomb. While Royal Bank of Canada reiterated its “outperform” rating with a $20.00 price target, Needham & Company LLC maintained a “hold” rating. Raymond James, initiating coverage on the company, assigned an “outperform” rating and a $19.00 price target. However, HC Wainwright lowered its target from $20.00 to $19.00, despite maintaining a “buy” rating.
Overall, the stock currently holds a “Moderate Buy” consensus rating from six analysts, with an average price target of $18.86.
Bausch + Lomb, an eye health company operating globally, recently reported earnings for the quarter ending July 31st. The company achieved $0.13 EPS, meeting analysts’ expectations, and reported revenue of $1.22 billion, exceeding estimates of $1.17 billion.
The company’s financial performance, combined with the recent positive outlook from some analysts, appears to have contributed to the increased trading activity and interest in Bausch + Lomb. Institutional investors and hedge funds have also shown active interest in the company, with several increasing their holdings in recent quarters.
However, it’s important to note that the stock remains subject to volatility and varying perspectives from analysts, suggesting further price fluctuations may be expected in the future.
First Piper 